Does FLUPENTIXOL\MELITRACEN Cause Basal cell carcinoma? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Basal cell carcinoma have been filed in association with FLUPENTIXOL\MELITRACEN. This represents 9.1% of all adverse event reports for FLUPENTIXOL\MELITRACEN.
6
Reports of Basal cell carcinoma with FLUPENTIXOL\MELITRACEN
9.1%
of all FLUPENTIXOL\MELITRACEN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From FLUPENTIXOL\MELITRACEN?
Of the 6 reports, 3 (50.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLUPENTIXOL\MELITRACEN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does FLUPENTIXOL\MELITRACEN Cause?
Tremor (10)
Drug ineffective (9)
Hallucination (9)
Anxiety (7)
Constipation (7)
Dysphagia (7)
Muscular weakness (7)
Fatigue (6)
Gait disturbance (6)
Oedema (6)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)